Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of May 21, 2026, OGN trades at $13.39 with a market cap of $3.52B and a P/E ratio of 14.29. OGN moved +0.34% today. Year to date, OGN is +80.91%; over the trailing twelve months it is +53.65%. Its 52-week range spans $5.69 to $19.41. Analyst consensus is neutral with an average price target of $11.25. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OGN recently traded at $13.39. Market cap is $3.52B. P/E ratio is 14.29. Revenue is $6.16B.
| Metric | Value |
|---|---|
| Price | $13.39 |
| Market Cap | $3.52B |
| P/E Ratio | 14.29 |
| EPS | $0.94 |
| Dividend Yield | 0.02% |
| 52-Week High | $19.41 |
| 52-Week Low | $5.69 |
| Volume | 17 |
| Avg Volume | 0 |
| Revenue (TTM) | $6.16B |
| Net Income | $246.00M |
| Gross Margin | 52.81% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.22B | $187.00M | $0.72 |
| 2024 | $6.40B | $864.00M | $3.36 |
| 2023 | $6.26B | $1.02B | $4.01 |
| 2022 | $6.17B | $917.00M | $3.61 |
5 analysts cover OGN: 0 strong buy, 0 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $11.25.